A Tehrani - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

A Tehrani

Showing results (41-50 of 43) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 43 results.

ESMO Open|June 30, 2026

Higher rates of immune-related adverse events in circulating tumor DNA (ctDNA)-negative patients following adjuvant checkpoint inhibitor therapyT Powles, K Madjar, B I Balas, et al.

Biomaterials Advances|November 30, 2023

MMP inhibition as a novel strategy for extracellular matrix preservation during whole liver decellularizationMohammadreza Kasravi, Alireza Yaghoobi, Tahereh Tayebi, et al.

European Journal of Neurology|April 22, 2019

Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease Study 2016S-M Fereshtehnejad, K Vosoughi, P Heydarpour, et al.

Pageof 5

Search research articles

Showing results (41-50 of 43) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 43 results.

ESMO Open|June 30, 2026

Higher rates of immune-related adverse events in circulating tumor DNA (ctDNA)-negative patients following adjuvant checkpoint inhibitor therapyT Powles, K Madjar, B I Balas, et al.

Biomaterials Advances|November 30, 2023

MMP inhibition as a novel strategy for extracellular matrix preservation during whole liver decellularizationMohammadreza Kasravi, Alireza Yaghoobi, Tahereh Tayebi, et al.

European Journal of Neurology|April 22, 2019

Burden of neurodegenerative diseases in the Eastern Mediterranean Region, 1990-2016: findings from the Global Burden of Disease Study 2016S-M Fereshtehnejad, K Vosoughi, P Heydarpour, et al.

Pageof 5